Rubius raises $100m funding to further support red-cell therapeutics development

This article was originally published here

US-based biotechnology company Rubius Therapeutics has raised $100m crossover financing to further support manufacturing and clinical development of red-cell therapeutics.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply